# Assessing a Risk Model for G6PD Deficiency

> **NCT03337152** · PHASE4 · TERMINATED · sponsor: **PATH** · enrollment: 54 (actual)

## Conditions studied

- Malaria, Vivax
- G6PD Deficiency

## Interventions

- **DRUG:** primaquine
- **DRUG:** chloroquine + primaquine

## Key facts

- **NCT ID:** NCT03337152
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-07
- **Primary completion:** 2018-08-21
- **Final completion:** 2018-10-21
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** study met study halting rules
- **Last updated:** 2021-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03337152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03337152, "Assessing a Risk Model for G6PD Deficiency". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03337152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*